Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasma cell | 8 studies | 40% ± 13% | |
| plasmablast | 7 studies | 43% ± 24% | |
| ciliated cell | 6 studies | 22% ± 6% | |
| plasmacytoid dendritic cell | 5 studies | 24% ± 10% | |
| IgA plasma cell | 3 studies | 23% ± 5% | |
| IgG plasma cell | 3 studies | 21% ± 4% | |
| epithelial cell | 3 studies | 27% ± 9% |
Insufficient scRNA-seq data for expression of GMPPB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2690.00 | 245 / 245 | 100% | 29.15 | 501 / 502 |
| thymus | 100% | 2682.40 | 653 / 653 | 100% | 13.48 | 603 / 605 |
| pancreas | 100% | 2882.57 | 328 / 328 | 99% | 12.31 | 177 / 178 |
| uterus | 100% | 1541.75 | 170 / 170 | 99% | 13.58 | 456 / 459 |
| breast | 100% | 1478.60 | 459 / 459 | 99% | 14.63 | 1110 / 1118 |
| lung | 100% | 2030.39 | 578 / 578 | 99% | 11.36 | 1146 / 1155 |
| skin | 100% | 1395.67 | 1809 / 1809 | 99% | 12.58 | 468 / 472 |
| stomach | 100% | 1789.04 | 359 / 359 | 99% | 12.33 | 283 / 286 |
| ovary | 100% | 1288.23 | 180 / 180 | 99% | 10.09 | 425 / 430 |
| intestine | 100% | 1603.36 | 965 / 966 | 99% | 15.09 | 521 / 527 |
| bladder | 100% | 1459.14 | 21 / 21 | 99% | 13.19 | 497 / 504 |
| liver | 100% | 2162.25 | 226 / 226 | 98% | 9.27 | 399 / 406 |
| kidney | 100% | 1457.89 | 89 / 89 | 97% | 7.56 | 872 / 901 |
| adrenal gland | 100% | 2497.76 | 258 / 258 | 96% | 8.92 | 220 / 230 |
| esophagus | 100% | 1340.48 | 1444 / 1445 | 96% | 7.85 | 175 / 183 |
| brain | 95% | 703.73 | 2521 / 2642 | 99% | 7.87 | 697 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.02 | 29 / 29 |
| spleen | 100% | 2391.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.19 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.60 | 1 / 1 |
| adipose | 100% | 1213.87 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1191.59 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 1016.30 | 827 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 676.83 | 758 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 6.13 | 75 / 80 |
| peripheral blood | 89% | 1126.54 | 829 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009298 | Biological process | GDP-mannose biosynthetic process |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005525 | Molecular function | GTP binding |
| GO_0004475 | Molecular function | mannose-1-phosphate guanylyltransferase (GTP) activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GMPPB |
| Protein name | GDP-mannose pyrophosphorylase B mannose-1-phosphate guanylyltransferase (EC 2.7.7.13) Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta) |
| Synonyms | |
| Description | FUNCTION: Catalyzes the formation of GDP-mannose, an essential precursor of glycan moieties of glycoproteins and glycolipids. . |
| Accessions | ENST00000480687.5 [Q9Y5P6-1] ENST00000677393.1 A0A7I2YQI5 A0A7I2V2Y5 A0A7I2V4B5 ENST00000495627.2 ENST00000678853.1 ENST00000678010.1 ENST00000308388.7 [Q9Y5P6-1] A0A7I2V691 ENST00000308375.10 [Q9Y5P6-2] Q9Y5P6 |
